CTI BIOPHARMA CORP Indenture Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture Agreement for 10% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association (December 5, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture for 9.66% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association (October 22, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture Agreement for 15.5% Convertible Senior Notes Due 2012 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture for 10% Convertible Senior Notes Due 2012 between Cell Therapeutics, Inc. and U.S. Bank National Association (September 15, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture for Series B 18.33% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association (August 19, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture Agreement for 18.33% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture for 15% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association (June 12, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture for 13.5% Convertible Senior Notes Due 2014 between Cell Therapeutics, Inc. and U.S. Bank National Association (April 30, 2008)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture Agreement for 9% Convertible Senior Notes Due 2012 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2008
Indenture Agreement for 5.75% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association (12/12/2007)
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2007
Indenture Agreement for 7.5% Convertible Senior Notes Due 2011 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2006
Indenture Agreement for 6.75% Convertible Senior Notes Due 2010 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2005
Indenture Agreement for 4% Convertible Senior Subordinated Notes Due 2010 between Cell Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2003
Indenture Agreement for 5.75% Convertible Senior Subordinated Notes Due 2008 between Cell Therapeutics, Inc. and State Street Bank and Trust Company
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2003
Indenture Agreement for 5.75% Convertible Subordinated Notes Due 2008 between Cell Therapeutics, Inc. and State Street Bank and Trust Company of California, N.A.
Indenture Agreements
CTI BIOPHARMA CORP
Biotechnology
NY
2001